Robert Breedon > Gowling WLG > London, England > Lawyer Profile
Gowling WLG Offices
4 MORE LONDON RIVERSIDE
- Go to...
Robert Breedon is a partner in Gowling WLG’s healthcare team. He is an experienced healthcare lawyer having worked for the Department of Health for many years and having advised a number of clients in the healthcare sector. He was extensively involved in the Government’s Independent Sector Treatment Centre programme and in the Department’s preparation for a pandemic flu outbreak in the UK. He is experienced in a range of commercial transactions and also acts for a number of commercial clients and in-house legal teams. He advises a large number of commissioners and providers of healthcare services.
Trained Slaughter and May, qualified 1989. Moved to Southern Electric plc (1990) as in-house lawyer before joining Morgan Cole in 1992. Became a partner in 1995. Joined the BOC Group in 2005 as in-house counsel before establishing his own practice in 2006. Joined Wragge & Co in April 2011. Wragge Lawrence Graham & Co, partner, 2014.
Bristol University (1986 LLB (Hons)).
Holder of private pilot’s licence. Member of the West London Aero Club.
Gowling WLG’s ‘commercially savvy’ and ‘modern, forward-looking practice’ is ‘continually thinking about how best to meet the client’s requirements’ on large-scale and business-critical commercial agreements. The team has experience in route-to-market issues, supply chain contracts, strategic alliances, outsourcings and procurement arrangements and in handling large national and international projects; in a recent highlight, the team acted for the Birmingham 2022 Commonwealth Games on all commercial issues relating to the delivery of the games. David Lowe heads up the group, which also fields the ‘pragmatic and commercial’ Sarah Riding and Robert Breedon, who advises public sector and healthcare clients.
Gowling WLG’s cross-departmental life sciences sector group handles the full spectrum of life sciences work encompassing transactions, patent disputes, regulatory issues and commercial work. The team counts several high-profile pharmaceutical companies on its client roster, including AstraZeneca and BioNTech. The firm also fields a distinct health and care team, which acts for a range of health and care service providers and investors, and is highly regarded for its real estate work relating to care homes and senior living facilities. Patrick Duxbury and Robert Breedon lead the group; Duxbury focuses on life sciences transactions and Breedon handles corporate work in the health and care sectors.
Gowling WLG is especially capable at handling large scale health and social care transactions. The firm has aided clients that have been critical to the COVID-19 response including AstraZeneca, the Office for National Statistics and the Department of Health and Social Care. Robert Breedon advises the DHSC’s Test and Trace Team. Hugh Maule specialises in corporate transactions, private equity and venture capital matters.
- Commercial contracts - London > Corporate and commercial
- Life sciences and healthcare - London > Industry focus
Top Tier Firm Rankings
- Investment fund formation and management > Listed funds
- Projects, energy and natural resources > Water
- Corporate and commercial > Commercial contracts
- Dispute resolution > Commercial litigation: mid-market
- Real estate > Commercial property: development
- Real estate > Commercial property: investment
- Corporate and commercial > Equity capital markets – small-mid cap
- Projects, energy and natural resources > Infrastructure
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- TMT (technology, media and telecoms) > Intellectual property: trade marks, copyright and design
- Industry focus > Life sciences and healthcare
- Employment > Pensions (non-contentious)
- Employment > Pensions: dispute resolution
- Industry focus > Retail and consumer
- Real estate > Commercial property: corporate occupiers
- Real estate > Construction: contentious
- Real estate > Construction: non-contentious
- Industry focus > Emerging markets
- Corporate and commercial > EU and competition: trade, WTO anti-dumping and customs
- Crime, fraud and licensing > Fraud: civil
- Employment > Health and safety
- Public sector > Healthcare
- Projects, energy and natural resources > Mining and minerals
- Real estate > Planning
- Projects, energy and natural resources > Power (including electricity, nuclear and renewables)
- Real estate > Property litigation
- Transport > Rail
- Investment fund formation and management > Real estate funds
- Private client > Contentious trusts and probate
- TMT (technology, media and telecoms) > Fintech
- TMT (technology, media and telecoms) > IT and telecoms
- Corporate and commercial > M&A: lower mid-market deals, £50m-£500m
- TMT (technology, media and telecoms) > Media and entertainment (including media finance)
- Corporate and commercial > Private equity: transactions - mid-market deals (up to £250m)
- Real estate > Property finance
- Real estate > Social housing: finance
- Industry focus > TMT
- Corporate and commercial > Venture capital
- Public sector > Administrative and public law
- Dispute resolution > Banking litigation: investment and retail
- Real estate > Environment
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: contentious
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration